Abstract

Breast cancer remains a leading cause of cancer-related morbidity and mortality worldwide. Early detection and accurate prognostication are essential for improving patient outcomes and guiding treatment decisions. In recent years, significant advancements have been made in identifying novel biomarkers that hold promise for enhancing the early detection and prognostic assessment of breast cancer. This article provides an overview of innovative biomarkers, including circulating tumor cells, circulating tumor DNA, microRNAs, exosomes and radiomic features, and their potential applications in breast cancer management. Understanding the role of these biomarkers in early detection and prognosis can pave the way for personalized approaches to breast cancer diagnosis and treatment.